Envista (NYSE:NVST) Rating Lowered to “Buy” at Wall Street Zen

Envista (NYSE:NVST) was downgraded by research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Sunday.

A number of other equities research analysts have also weighed in on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research report on Monday, December 29th. Mizuho set a $19.00 price objective on shares of Envista in a research note on Monday, November 3rd. Stifel Nicolaus set a $25.00 price objective on shares of Envista in a report on Thursday, October 30th. Evercore ISI reissued an “outperform” rating on shares of Envista in a report on Friday, October 31st. Finally, Barclays initiated coverage on Envista in a research report on Monday, December 8th. They set an “overweight” rating and a $24.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $21.77.

Envista Stock Performance

NYSE NVST opened at $25.24 on Friday. The business’s 50 day moving average price is $21.59 and its 200-day moving average price is $20.82. The company has a market cap of $4.15 billion, a P/E ratio of 280.48, a P/E/G ratio of 1.13 and a beta of 0.99. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $25.41.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. During the same period in the prior year, the company posted $0.12 EPS. The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. Sell-side analysts predict that Envista will post 1 earnings per share for the current year.

Hedge Funds Weigh In On Envista

Institutional investors have recently modified their holdings of the business. Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new stake in Envista in the 4th quarter valued at about $203,000. Pallas Capital Advisors LLC boosted its holdings in Envista by 37.4% in the fourth quarter. Pallas Capital Advisors LLC now owns 21,161 shares of the company’s stock valued at $459,000 after purchasing an additional 5,759 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Envista by 26.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 86,137 shares of the company’s stock valued at $1,999,000 after purchasing an additional 18,084 shares during the last quarter. GAMMA Investing LLC raised its holdings in Envista by 31.3% during the fourth quarter. GAMMA Investing LLC now owns 3,281 shares of the company’s stock worth $71,000 after purchasing an additional 783 shares in the last quarter. Finally, Tudor Investment Corp ET AL purchased a new position in shares of Envista in the 3rd quarter valued at $1,664,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.